Research programme - neurological disorders therapeutics - Praxis Precision Medicines
Alternative Names: Research programme: neurological disorders therapeutics - Praxis Precision Medicines/Ligand PharmaceuticalsLatest Information Update: 03 Sep 2021
At a glance
- Originator Praxis Precision Medicines
- Developer Ligand Pharmaceuticals; Praxis Precision Medicines
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders